MCOV B logo

Medicover AB (publ) Stock Price

OM:MCOV B Community·SEK 38.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

MCOV B Share Price Performance

SEK 255.00
69.40 (37.39%)
21.6% undervalued intrinsic discount
SEK 325.27
Fair Value
SEK 255.00
69.40 (37.39%)
21.8% undervalued intrinsic discount
SEK 326.23
Fair Value
Price SEK 255.00
AnalystHighTarget SEK 326.23
AnalystConsensusTarget SEK 268.90
AnalystLowTarget SEK 219.70

MCOV B Community Narratives

AnalystHighTarget·Updated
Fair Value SEK 325.27 21.6% undervalued intrinsic discount

Digitalization And Diagnostics Will Unlock Secular Private Healthcare Growth

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value SEK 267.22 4.6% undervalued intrinsic discount

Demographic Shifts And Digitalization Will Unlock Healthcare Opportunity

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AnalystLowTarget·Updated
Fair Value SEK 219.05 16.4% overvalued intrinsic discount

Rising European Labor Costs And Regulatory Burdens Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent MCOV B News & Updates

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Sep 24
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Sep 01
Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Jul 27
Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Medicover (STO:MCOV B) Seems To Use Debt Quite Sensibly

Jul 22
Medicover (STO:MCOV B) Seems To Use Debt Quite Sensibly

Medicover AB (publ) Key Details

€2.3b

Revenue

€1.7b

Cost of Revenue

€508.6m

Gross Profit

€465.2m

Other Expenses

€43.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 05, 2025
Earnings per share (EPS)
0.29
Gross Margin
22.52%
Net Profit Margin
1.92%
Debt/Equity Ratio
184.8%

Medicover AB (publ) Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

High growth potential with proven track record.

2 Risks
3 Rewards

About MCOV B

Founded
1995
Employees
47000
CEO
John Stubbington
WebsiteView website
www.medicover.com

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Swedish Market Performance

  • 7 Days: 2.5%
  • 3 Months: 3.2%
  • 1 Year: -1.0%
  • Year to Date: 3.1%
The market has climbed 2.5% in the last 7 days, lead by the Industrials sector with a gain of 3.5%. As for last year, the market performance has been flat. Looking forward, earnings are forecast to grow by 16% annually. Market details ›